I am sure Calypte would be aware if they had they only test that would work correctly on infants.
Nevertheless, I admire runcaly and his efforts to double check this potential market. If Calypte were to ever develop a test where none exised before, even I, as one of their harshest critics would join in in trying to help Calypte market that product.
Runcaly's efforts might at least get some attention paid to Calypte's products by the Doctors without Borders group.
On the other hand if this "search" were to be used as a means of "pumping" up the stock price, the old bloodhound will be on duty.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.